More than 5 years of experience in equity analysis in LatAm. We provide our clients with in-depth research and insights to help them make informed investment decisions.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relati ...

Key Takeaways Suzano will hold 51% of a $3.4B tissue joint venture with Kimberly-Clark, transaction to close in mid-2026. The JV spans 22 plants across 14 countries with 1M-ton annual output and $3.3B in 2024 net sales. Suzano will pay $1.734B in cash at closing, aligning with its strategy of scalable, efficient growth.Suzano S.A. (SUZ) and Kimberly-Clark Corporation (KMB) announced that they would create a $3.4-billion joint venture that will manufacture consumer and professional tissue products. Suzano ...

Forms Strategic Partnership with Suzano That Will Create Preeminent International Tissue and Professional Products CompanySharpens Kimberly-Clark's Focus on Higher Growth, Higher Margin Personal Care and North America Tissue and Professional Categories Clears Path to Capture Huge Opportunities Across Kimberly-Clark and Newly Formed Venture to Drive Significant Shareholder ReturnsDALLAS and SÃO PAULO, June 5, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark" or the "Company") to ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today May 12th:Suzano (SUZ) : This company which is a producer of eucalyptus pulp as well as paper producers, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.Suzano has a PEG ratio of 0.08 compared with 0.32 for the industry. The company possesses a Growth Score of A.Great Lakes Dredge & Dock (GLDD) This comp ...

If you thought our angle on this company was interesting, you may want to check out our idea room, The Value Lab . We focus on long-only value ideas of interest to us, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, our gang could help broaden your horizons and give some in ...

书赞桉诺帕尔杜河畔里巴斯工厂 上海2025年5月9日 /美通社/ -- 全球大型商品浆生产商书赞桉诺公布2025年第一季度业绩报告，实现净收 入116亿雷亚尔，较去年同期（2024年第一季度）增长22%。这一创纪录表现主要得益于汇率优势、新 投产的帕尔杜河畔里巴斯（Ribas do Rio Pardo）浆厂带来的销量增长、纸张销量与价格提升，以及近期 收购的美国纸板工厂的积极贡献。 书赞桉诺林地 尽管本季度安排了多条产线的计划性停机维护（包括特雷斯拉瓜斯、穆库里、阿拉克鲁斯及帕尔杜河畔 里巴斯工厂），公司仍实现了超300万吨的季度总销量，同比增长12%。其中木浆销量270万吨，同比增 长10%，纸张销量39万吨，同比增长25%。 调整后息税折旧摊销前利润（EBITDA）达49亿雷亚尔，同比增长7%。经营性现金收入达26亿雷亚尔， 同比增长5%。受美元计价债务及对冲操作的会计影响，净利润达到63亿雷亚尔。 书赞桉诺首席执行官Beto Abreu表示： 报告期末，书赞桉诺以美元计的净杠杆率为3.0倍。本季度公司分配22亿雷亚尔用于自主性股权利息支 付，并投入36亿雷亚尔用于资产维护、现代化改造及产能扩张等资本性支 ...

FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2025. Commission File Number 001-38755 Suzano S.A. (Exact name of registrant as specified in its charter) SUZANO INC. (Translation of Registrant's Name into English) Av. Professor Magalhaes Neto, 1,752 10th Floor, Rooms 1010 and 1011 Salvador, Brazil 41 810-012 (Address of principal executive office) ...

Financial Performance - Net sales increased by 19.2% to R$47,403.3 million in 2024 from R$39,755.6 million in 2023, driven by higher cellulose prices and sales volume [358]. - Net sales from pulp rose by 22.5% to R$37,593.5 million in 2024, accounting for 79.3% of total net sales, influenced by an 8% appreciation of the USD against the BRL and a 6.3% increase in sales volume [359]. - Gross profit increased by 36.3% to R$20,001.8 million in 2024, with a gross margin of 42.2% compared to 36.9% in 2023, primarily due to increased pulp sales prices and volume [365]. - Operating profit before net financial income rose by 28.4% to R$15,691.1 million in 2024, with an operating margin of 33.1% compared to 30.7% in 2023 [369]. - Net income decreased by 149.9% to a loss of R$7,044.7 million in 2024, compared to a gain of R$14,106.4 million in 2023 [373]. Expenses and Investments - Selling expenses increased by 13.2% to R$2,938.5 million in 2024, attributed to higher sales volume and the acquisition of Kimberly Clark's tissue business in Brazil [366]. - General and administrative expenses surged by 36.2% to R$2,619.8 million in 2024, mainly due to increased personnel costs [366]. - The company plans to invest R$7,677.4 million in maintenance capital expenditures for 2024, primarily financed by cash and cash generation [381]. - Capital expenditures totaled R$17,119.8 million in 2024, down from R$18,576.6 million in 2023, with R$7,610.0 million allocated to industrial and forestry maintenance [386]. - The approved budget for capital expenditures in 2025 is R$12,380.8 million, reflecting a decrease primarily due to the Cerrado project's investment schedule [387]. Cash Flow and Indebtedness - Cash and cash equivalents as of December 31, 2024, were R$9,018.8 million, with 70% denominated in reais and 30% in U.S. dollars [378]. - Net cash provided by operating activities increased to R$20,604.4 million in 2024 from R$17,315.5 million in 2023, a rise of R$3,288.9 million due to higher pulp prices and currency appreciation [383]. - Net cash used in investing activities decreased to R$20,512.7 million in 2024 from R$26,035.3 million in 2023, with R$9,190.6 million allocated to property, plant, and equipment [384]. - Total consolidated outstanding indebtedness reached R$101,435.5 million as of December 31, 2024, with R$10,501.4 million classified as current indebtedness [388]. Research and Development - Research and development investments amounted to R$174.0 million in 2024, focusing on increasing forestry productivity and developing new products [409]. - The company produced over 320,000 seedlings and 17 new potential clones in 2024 through its Transition Nursery initiative [411]. - FuturaGene's investments in R&D ensure significant independence from external sources for intellectual property and innovation [422]. - In 2024, the company filed 11 new technology patents and protected one new eucalyptus variety, focusing on biorefining and paper products [422]. Innovations and Sustainability - The company achieved a milestone in biorefinery with the sale of 20,000 tonnes of Ecolig lignin, diversifying its portfolio of certified applications [419]. - The Paper and Packaging projects in 2024 emphasized the replacement of fossil products and introduced biodegradable solutions for hot liquids [420]. - FuturaGene's Forest Management strategy focuses on increasing productivity and reducing operational costs through technological innovation [416]. - The company launched certified grammages for food in the Greenpack® Line and introduced the Bluecup Bio® line for biodegradable solutions [420]. Financial Instruments and Compliance - The company raised R$5.9 billion in debentures in May 2024, with various interest rates and amortization schedules [394]. - The company issued panda bonds amounting to CNY1,200,000 (equivalent to US$166.0 million) on November 15, 2024, with a fixed interest rate of 2.8% [403]. - The company has no financial covenants as of December 31, 2024, and is in compliance with all other non-financial covenants [405]. Regulatory Approvals and Patents - In 2024, FuturaGene received three new commercial approvals for genetically modified eucalyptus varieties, bringing the total to eleven approvals by the end of the year [415]. - FuturaGene holds a total of 804 granted patents and patent applications, including 75 protected eucalyptus varieties and over 404 potential new varieties under evaluation [421]. Market Trends - The primary trends influencing sales and production include pulp purchase patterns, pulp prices, and global economic conditions [425].

Group 1 - Suzano (NYSE: SUZ) is positioned to benefit from the recent tariff draw-down, indicating a favorable market environment for the company [2] - The company has a clear deleveraging path, having achieved a 10% quarterly reduction in debt, which enhances its financial stability [2] - The Value Lab offers a portfolio with a target yield of about 4%, focusing on international mispriced equities, which may include companies like Suzano [1][2] Group 2 - The Valkyrie Trading Society consists of analysts who focus on high conviction, downside-limited investment ideas in developed markets, aiming for non-correlated and outsized returns [3] - The society operates as long-only investors, indicating a strategy that avoids short selling and focuses on capital appreciation [3]

Core Insights - Investors are evaluating the value opportunities between Suzano S.A. Sponsored ADR (SUZ) and International Paper (IP) [1] Valuation Metrics - SUZ has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while IP has a Zacks Rank of 3 (Hold) [3] - The forward P/E ratio for SUZ is 4.47, significantly lower than IP's forward P/E of 17.75 [5] - SUZ's PEG ratio is 0.08, compared to IP's PEG ratio of 0.34, suggesting SUZ is expected to grow earnings at a faster rate relative to its price [5] - SUZ has a P/B ratio of 2.09, slightly lower than IP's P/B ratio of 2.19, indicating a better valuation relative to book value [6] - Overall, SUZ has a Value grade of A, while IP has a Value grade of C, highlighting SUZ as the superior value option [6]